Gray marketing of pharmaceuticals.
Copyright policy )Gray marketing of pharmaceuticals.
Pharmaceutical marketers in the European Union are constrained by regulated prices, opening up opportunities for gray marketers. The authors investigate the legal framework that regulates gray markets by summarizing and analyzing relevant European Court of Justice decisions that favor gray marketers and actually foster parallel trade. Before marketing managers can develop effective strategies in this marketplace, they must first understand the precedents of the legal system in which they will be operating.
- Villanova University United States
Economic Competition, Drug Industry, Commerce, Planning Techniques, Legislation, Drug, Drug Costs, Organizational Innovation, United States, Europe, European Union
Economic Competition, Drug Industry, Commerce, Planning Techniques, Legislation, Drug, Drug Costs, Organizational Innovation, United States, Europe, European Union
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!